The vitamin D signaling pathway plays a critical role in tumor suppression through interactions with its active metabolites, such as 1,25-dihydroxyvitamin D3, which bind to the vitamin D receptor (VDR) and other nuclear receptors like RORα and RORγ. Here, RORC is linked to neoplasm.